ARTICLE | Company News
Management tracks
August 11, 2016 7:00 AM UTC
Cancer company Oric Pharmaceuticals Inc. (South San Francisco, Calif.) named Ashraf Hanna CEO and Darcy Mootz CBO. Hanna was VP of commercial and medical affairs finance at the Genentech unit of Roche (SIX:ROG; OTCQX:RHHBY). Mootz was VP of corporate development at Achaogen Inc. (NASDAQ:AKAO).
Antibody-drug conjugate developer Immunogen Inc. (NASDAQ:IMGN) said chief development officer Charles Morris will leave the company on Sept. 2. ...